What should you know about BRAF wild-type melanoma?

Wild type is a laboratory term for a gene that does not carry the particular alteration being tested. In melanoma, it is often used when a BRAF change was not found. It is not a description of the mole's appearance, and it does not tell you the stage. A pathology report, lymph-node evaluation, examination, and scans when needed provide the wider clinical context.

The result can help the team avoid choosing a medicine aimed at a BRAF alteration that is not present. Ask whether the test covered other relevant tumour changes and whether its result was obtained from the most representative tissue sample.

Review the pathology report with your dermatologist or oncology team. For local melanoma, surgical excision can remove the tumour, with the amount of surrounding skin guided by pathology. A sentinel lymph node biopsy may be discussed in selected cases to add staging information. If melanoma is advanced, immunotherapy or another systemic treatment may be considered based on the disease pattern and your health.

Attend skin and lymph-node checks even after treatment. Protect healing skin from sun exposure, watch for new or changing lesions, and keep records of symptoms and medicines so your team can act on useful details.

Seek prompt review for a new changing mole, bleeding lesion, a persistent sore, a growing lump, or swelling around a treated area. Go to emergency care for a seizure, sudden weakness, confusion, severe breathlessness, or a sudden severe headache. These symptoms are not a diagnosis, but delay could matter. If receiving systemic treatment, report severe diarrhoea, new cough, fever, extensive rash, or yellowing skin promptly.

Does wild type refer only to BRAF, or were other genes tested? What is my melanoma stage? Do I need surgery or a sentinel lymph node biopsy? Which treatment is recommended if the melanoma has spread? What follow-up checks will I need, and which changes should I report quickly?